MX9301694A - ANTIVIRAL PEPTIDES - Google Patents

ANTIVIRAL PEPTIDES

Info

Publication number
MX9301694A
MX9301694A MX9301694A MX9301694A MX9301694A MX 9301694 A MX9301694 A MX 9301694A MX 9301694 A MX9301694 A MX 9301694A MX 9301694 A MX9301694 A MX 9301694A MX 9301694 A MX9301694 A MX 9301694A
Authority
MX
Mexico
Prior art keywords
antiviral peptides
antiviral
peptides
prevention
useful
Prior art date
Application number
MX9301694A
Other languages
Spanish (es)
Inventor
Colin William Greengrass
Stephen Derek Albert Street
Peter John Whittle
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9301694A publication Critical patent/MX9301694A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Esta invención está relacionada con ciertos derivados peptídicos que contienen un grupo heterocíclico que son útiles en el tratamiento o la prevención de infecciones retrovirales humanas.This invention relates to certain heterocyclic group-containing peptide derivatives that are useful in the treatment or prevention of human retroviral infections.

MX9301694A 1992-03-25 1993-03-25 ANTIVIRAL PEPTIDES MX9301694A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929206462A GB9206462D0 (en) 1992-03-25 1992-03-25 Antiviral peptides

Publications (1)

Publication Number Publication Date
MX9301694A true MX9301694A (en) 1993-09-01

Family

ID=10712788

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301694A MX9301694A (en) 1992-03-25 1993-03-25 ANTIVIRAL PEPTIDES

Country Status (11)

Country Link
CN (1) CN1077716A (en)
GB (1) GB9206462D0 (en)
HR (1) HRP930283A2 (en)
IL (1) IL105099A0 (en)
IS (1) IS3988A (en)
MA (1) MA22838A1 (en)
MX (1) MX9301694A (en)
MY (1) MY131321A (en)
OA (1) OA10054A (en)
UY (1) UY23555A1 (en)
ZA (1) ZA932079B (en)

Also Published As

Publication number Publication date
CN1077716A (en) 1993-10-27
MA22838A1 (en) 1993-10-01
OA10054A (en) 1996-10-14
IS3988A (en) 1993-09-26
ZA932079B (en) 1994-09-26
GB9206462D0 (en) 1992-05-06
MY131321A (en) 2007-08-30
IL105099A0 (en) 1993-07-08
UY23555A1 (en) 1993-09-08
HRP930283A2 (en) 1997-08-31

Similar Documents

Publication Publication Date Title
DE69432984D1 (en) THERAPEUTIC SUBSTITUTED GUANIDINE
UY25074A1 (en) FARNESIL PROTEIN TRANSFERASE INHIBITORS
FI941580A (en) Bicyclic ansamycins
SV1996000030A (en) RECOMBINANT PROTEINS FOR OBESITY (OB), REF. 13209-SV
PT883687E (en) RECEPTORS OF CHIMIOCINES C-C, CKR-5, CC, THEIR DERIVATIVES AND THEIR USES
ATE193839T1 (en) PURIFICATION OF PROTEINS
SV1997000079A (en) OLANCEPINA DIHYDRATE D REF. X- 11062T
FI941826A (en) Methods and compositions for the prevention and / or therapeutic treatment of organ hypofunction
DK6893D0 (en) PEPTIDE
ES2076999T3 (en) RADIO-MARKED ANTICOAGULANT PEPTIDES.
ES2056180T3 (en) NEW DERIVATIVES OF 2'-HALOMETILIDEN, 2'-ETENILIDEN AND 2'-ETINIL CITIDINA.
MXPA94009086A (en) Therapeutic substituted guanidines.
DE69012901D1 (en) Hemoregulating peptides.
ES2117624T3 (en) ANTICOAGULANT PEPTIDES.
ATE201693T1 (en) HEMOREGULATING PEPTIDES
MX9301694A (en) ANTIVIRAL PEPTIDES
ATE142648T1 (en) ANTI-CLOTTING PEPTIDES
ES2131041T3 (en) ANTICOAGULANT PEPTIDES.
TR199802504T2 (en) Use of bucminsterflirin for the treatment of neurotoxic injuries.
MX9307047A (en) QUINAZOLINES AND SUBSTITUTED BENZMIDAZOLES COMPOUNDS.
ES2061908T3 (en) GONADOLIBERINE COMPETITIVE ANTAGONISTS.
DK0391224T3 (en) Drug and its use in the treatment of parasitoses
DK0967986T3 (en) Use of human alpha1-acid glycoprotein for the preparation of a pharmaceutical composition
DE69433763D1 (en) LINEAR AND CYCLIC PEPTIDES FOR THE TREATMENT OR PREVENTION OF ECCEM AND DERMATITIS
GR1001502B (en) Hemoregulatory peptides.